-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, EeC4CUHaQy0XhsSt6/4H3m/J1+NeXrqUD/1oT7ZCbbtP9wIE8DpxTTvRVKfia8A2 7RVT771ujy12lOglVPNsjA== 0001181431-05-055991.txt : 20051007 0001181431-05-055991.hdr.sgml : 20051007 20051007171111 ACCESSION NUMBER: 0001181431-05-055991 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20051005 FILED AS OF DATE: 20051007 DATE AS OF CHANGE: 20051007 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: OXIS INTERNATIONAL INC CENTRAL INDEX KEY: 0000109657 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 941620407 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6040 N CUTTER CIRCLE STE 317 CITY: PORTLAND STATE: OR ZIP: 97217 BUSINESS PHONE: 5032833911 MAIL ADDRESS: STREET 1: 6040 N CUTTER CIRCLE STE 317 CITY: PORTLAND STATE: OR ZIP: 97217 FORMER COMPANY: FORMER CONFORMED NAME: DDI PHARMACEUTICALS INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: DIAGNOSTIC DATA INC /DE/ DATE OF NAME CHANGE: 19850312 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HAUSMAN MARVIN S MD CENTRAL INDEX KEY: 0001067956 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-08092 FILM NUMBER: 051130214 BUSINESS ADDRESS: BUSINESS PHONE: 5094275132 MAIL ADDRESS: STREET 1: 825 THIRD AVE STREET 2: 40TH FL CITY: NEW YORK STATE: NY ZIP: 10022 4 1 rrd94351.xml X0202 4 2005-10-05 0 0000109657 OXIS INTERNATIONAL INC OXIS.OB 0001067956 HAUSMAN MARVIN S MD 16031 SW PLEASANT HILL RD SHERWOOD OR 97140 1 1 0 0 Interim CFO Non-Statutory Stock Option (Right to Buy) 0.37 2005-10-05 2005-10-05 4 A 0 108000 0.37 A 2005-10-05 2015-10-04 Common Stock 108000 209695 D 9,000 shares exercisable at any time from and including October 5, 2005, and additional 9,000 shares on each of the following 30 day periods (fully exercisable at 9/5/2006) /s/Marvin S. Hausman 2005-10-07 -----END PRIVACY-ENHANCED MESSAGE-----